Cineverse stock price target lowered to $9 by Benchmark on Toxic Avenger performance
NegativeFinancial Markets

Cineverse's stock price target has been lowered to $9 by Benchmark, following disappointing performance from its recent release, 'Toxic Avenger.' This adjustment reflects concerns about the film's reception and its impact on the company's financial outlook. Investors should take note, as this could signal challenges ahead for Cineverse in a competitive market.
— Curated by the World Pulse Now AI Editorial System










